KR960702322A - 활성성분으로서의 디클로로메틸렌디포스폰산을 함유하며 약효가 개선된 정제 (more easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent) - Google Patents

활성성분으로서의 디클로로메틸렌디포스폰산을 함유하며 약효가 개선된 정제 (more easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent)

Info

Publication number
KR960702322A
KR960702322A KR1019950705094A KR19950705094A KR960702322A KR 960702322 A KR960702322 A KR 960702322A KR 1019950705094 A KR1019950705094 A KR 1019950705094A KR 19950705094 A KR19950705094 A KR 19950705094A KR 960702322 A KR960702322 A KR 960702322A
Authority
KR
South Korea
Prior art keywords
diphosphonic acid
dichloromethylene diphosphonic
efficacy
improved
containing dichloromethylene
Prior art date
Application number
KR1019950705094A
Other languages
English (en)
Other versions
KR100263284B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25927331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR960702322(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE9307393U external-priority patent/DE9307393U1/de
Priority claimed from DE19934322057 external-priority patent/DE4322057A1/de
Application filed filed Critical
Publication of KR960702322A publication Critical patent/KR960702322A/ko
Application granted granted Critical
Publication of KR100263284B1 publication Critical patent/KR100263284B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019950705094A 1993-05-15 1993-07-24 활성성분으로서의 디클로로메틸렌디포스폰산을 함유하는 생체 이용률이 개선된 정제 KR100263284B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DEG9307393.3 1993-05-15
DE9307393U DE9307393U1 (de) 1993-05-15 1993-05-15 Tablette mit verbesserter Bioverfügbarkeit, enthaltend Dichlormethylendiphosphonsäure als Wirkstoff
DEP4322057.6 1993-07-02
DE19934322057 DE4322057A1 (de) 1993-07-02 1993-07-02 Tablette mit verbesserter Bioverfügbarkeit enthaltend Dichlormethylendiphosphonsäure als Wirkstoff
PCT/EP1993/001967 WO1994026310A1 (de) 1993-05-15 1993-07-24 Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff

Publications (2)

Publication Number Publication Date
KR960702322A true KR960702322A (ko) 1996-04-27
KR100263284B1 KR100263284B1 (ko) 2000-08-01

Family

ID=25927331

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950705094A KR100263284B1 (ko) 1993-05-15 1993-07-24 활성성분으로서의 디클로로메틸렌디포스폰산을 함유하는 생체 이용률이 개선된 정제

Country Status (25)

Country Link
US (1) US5650168A (ko)
EP (2) EP0625355B2 (ko)
JP (1) JP3699110B2 (ko)
KR (1) KR100263284B1 (ko)
CN (1) CN1041797C (ko)
AT (2) ATE128363T1 (ko)
AU (1) AU687744B2 (ko)
BR (1) BR9307859A (ko)
CA (1) CA2162470C (ko)
CZ (1) CZ287984B6 (ko)
DE (1) DE59300688D1 (ko)
DK (1) DK0625355T5 (ko)
ES (1) ES2065313T5 (ko)
FI (1) FI111519B (ko)
GR (2) GR940300095T1 (ko)
HU (1) HU220872B1 (ko)
IL (1) IL106743A (ko)
NO (1) NO307548B1 (ko)
NZ (1) NZ254765A (ko)
PL (1) PL173026B1 (ko)
RU (1) RU2134103C1 (ko)
SK (1) SK281193B6 (ko)
TW (1) TW350772B (ko)
UA (1) UA39884C2 (ko)
WO (1) WO1994026310A1 (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
CZ289261B6 (cs) * 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
PL1663175T3 (pl) * 2003-09-19 2012-09-28 Sun Pharma Advanced Res Co Ltd Doustny system podawania leku
US7151400B2 (en) * 2004-07-13 2006-12-19 Taiwan Semiconductor Manufacturing Company, Ltd. Boost-biased level shifter
CN100370972C (zh) * 2006-01-10 2008-02-27 北京申科联华科技有限公司 一种具有益气养阴、活血复脉功效的片剂及制备方法
MX2010001047A (es) * 2007-08-02 2010-03-03 Teijin Pharma Ltd Agente preventivo o agente terapéutico para enfermedades provocadas por metabolismo óseo anormal.
JP2011512349A (ja) * 2008-02-15 2011-04-21 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッド 経口放出制御錠剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2813121A1 (de) * 1977-03-29 1978-10-12 Procter & Gamble Verwendung von dichlormethan-diphosphonatverbindungen bei der bekaempfung von collagen-erkrankungen und zur wundheilung
US4634691A (en) * 1980-10-07 1987-01-06 The Procter & Gamble Company Method for inhibiting tumor metastasis
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
EP0275468B1 (de) * 1986-12-20 1991-02-06 Roche Diagnostics GmbH Clodronat-haltige Arzneimittel und Verfahren zur Herstellung derselben
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
FI83421C (fi) † 1989-06-21 1991-07-10 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt anvaendbara metylenbisfosfonsyraderivat.
ES2069424T3 (es) * 1991-02-26 1995-05-01 Procter & Gamble Pharma Metodos para el tratamiento de la osteoporosis.
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
WO1994014455A1 (en) * 1992-12-23 1994-07-07 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss

Also Published As

Publication number Publication date
ATE128363T1 (de) 1995-10-15
FI945313A0 (fi) 1994-11-11
NO944405D0 (no) 1994-11-17
EP0625355A1 (de) 1994-11-23
WO1994026310A1 (de) 1994-11-24
ES2065313T5 (es) 2004-01-01
EP0625355B2 (de) 2003-06-25
EP0625355B1 (de) 1995-09-27
IL106743A0 (en) 1993-12-08
EP0697890A1 (de) 1996-02-28
AU687744B2 (en) 1998-03-05
UA39884C2 (uk) 2001-07-16
SK281193B6 (sk) 2001-01-18
NO944405L (no) 1994-11-24
PL173026B1 (pl) 1998-01-30
CZ10095A3 (en) 1995-10-18
HUT70214A (en) 1995-09-28
CN1041797C (zh) 1999-01-27
NZ254765A (en) 1997-02-24
CZ287984B6 (cs) 2001-03-14
US5650168A (en) 1997-07-22
CN1095267A (zh) 1994-11-23
JPH08509697A (ja) 1996-10-15
AT128U1 (de) 1995-03-27
TW350772B (en) 1999-01-21
HU9403160D0 (en) 1995-02-28
ES2065313T1 (es) 1995-02-16
BR9307859A (pt) 1996-01-09
CA2162470A1 (en) 1994-11-24
CA2162470C (en) 1998-06-16
HU220872B1 (en) 2002-06-29
GR3017547T3 (en) 1995-12-31
GR940300095T1 (en) 1995-01-31
SK4895A3 (en) 1997-01-08
DE59300688D1 (de) 1995-11-02
NO307548B1 (no) 2000-04-25
PL307133A1 (en) 1995-05-02
JP3699110B2 (ja) 2005-09-28
FI111519B (fi) 2003-08-15
FI945313A (fi) 1994-12-13
DK0625355T3 (da) 1995-12-27
DK0625355T5 (da) 2003-12-01
ES2065313T3 (es) 1995-12-01
KR100263284B1 (ko) 2000-08-01
AU4702093A (en) 1994-12-12
DK0625355T4 (da) 2003-10-06
IL106743A (en) 1999-11-30
RU2134103C1 (ru) 1999-08-10

Similar Documents

Publication Publication Date Title
NO933239D0 (no) Bioeroderbar innretning for administering av aktive ingredienser
DE69525148T2 (de) Pharmazeutische formulierung
ATE253896T1 (de) Zwei oder mehrere wirkstoffe enthaltende pharmazeutische aerosolformulierungen
BR1100329A (pt) Composto e formulação farmacêutica
ATE183495T1 (de) 6-dimethylaminomethyl-1-phenyl-cyclo- hexanverbindungen als pharmazeutische wirkstoffe
ATE188961T1 (de) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1- olverbindungen als pharmazeutische wirkstoffe
NZ292995A (en) Organic phosphate surfactants; use in pharmaceutical aerosol formulations
DE69319207T2 (de) Anzeigevorrichtungen mit aktiver Matrix
DE69332648T2 (de) Grossflächige aktive Matrix
EP0645136A3 (en) Pharmaceutical preparation of the type: physiologically active substance with sustained release.
KR960702322A (ko) 활성성분으로서의 디클로로메틸렌디포스폰산을 함유하며 약효가 개선된 정제 (more easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent)
ITRM920928A1 (it) Eliminatore di ossigeno attivo e preparato farmaceutico che lo contiene.
FI961437A0 (fi) Vaikuttavan aineen luovuttava systeemi
FI925778A (fi) Farmaceutiskt aktiva bensokinazolinfoereningar
HU9201254D0 (en) Rapamicine-carbamates and medical preparations containing them as active agents
DE4294862T1 (de) Pharmazeutische Komposition
FI944974A (fi) Kolloidisesti dispergoituvia vaikuttavan aineen valmistemuotoja
HUP0004223A3 (en) 4-oxo-butynic acids and pharmaceutical composition containing them as active agent
PL327584A1 (en) Active substance quckly releasing tablet containing tolphenamica acid or its pharmaceutically acceptable salt
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung
EP0586812A3 (en) Medicines containing glicentin as an active ingredient.
DE69318153T2 (de) Antihypercholesterämisch-wirksame verbindungen, pharmazeutische präparate und verwendungen davon
ATE142880T1 (de) Penciclovir enthaltende pharmazeutische formulierung
ATA124091A (de) Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
ZA931875B (en) Dosage aerosols containing the active substance flezelasting and related structures

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130325

Year of fee payment: 14

EXPY Expiration of term